Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.

708 F. Supp. 2d 450, 2010 U.S. Dist. LEXIS 41772, 2010 WL 1685998
CourtDistrict Court, D. Delaware
DecidedApril 27, 2010
DocketCivil Action 09-286-SLR-MPT, 09-304-SLR-MPT, 09-305-SLR-MPT
StatusPublished
Cited by5 cases

This text of 708 F. Supp. 2d 450 (Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc., 708 F. Supp. 2d 450, 2010 U.S. Dist. LEXIS 41772, 2010 WL 1685998 (D. Del. 2010).

Opinion

MEMORANDUM ORDER

MARY PAT THYNGE, United States Magistrate Judge.

I. BACKGROUND

In this patent infringement case, defendants Apotex Inc. and Apotex Corp. (“Apo *452 tex”), Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. (“Par”), and Teva Pharmaceuticals USA, Inc. (“Teva”) move for issuance of Letters of Request for international judicial assistance pursuant to the Hague Evidence Convention. Plaintiff Pronova BioPharma Norge AS (“Pronova”) claims that defendants’ Abbreviated New Drug Applications (“ANDA”) for a generic version of GlaxoSmithKline’s LOVAZA® pharmaceutical product infringe its patents, specifically U.S. Patent Nos. 5,502,077 (“the '077 patent”) and 5,656,667 (“the '667 patent”). Defendants maintain that their ANDAs do not infringe Pronova’s patents and that the '077 and '667 patents are invalid and unenforceable. The defendants seek to obtain discovery from the inventors of the '077 and '667 patents and from several individuals who filed declarations in support of patentability during the prosecutions of those two patents. These inventors and declarants from whom discovery is presently sought reside in either Norway or Sweden.

II. LEGAL STANDARD

“The Hague Evidence Convention serves as an alternative or ‘permissive’ route to the federal Rules of Civil Procedure for the taking of evidence abroad from litigants and third parties alike.” 1 “The Convention allows judicial authorities in one signatory country to obtain evidence located in another signatory country ‘for use in judicial proceedings, commenced or contemplated.’ ” 2 The United States, Sweden, and Norway are contracting states under the Hague Evidence Convention. Letters of Request are one method of taking evidence pursuant to the Convention. 3 Upon receipt of a Letter of Request, which must provide specific information regarding the lawsuit and the information sought to be discovered, the signatory state “ ‘shall [then] apply the appropriate measure of compulsion’ as is customary ‘for the execution of orders issued by the authorities of its own country.’” 4 Individuals to whom a Letter of Request is directed have the right to refuse to give evidence to the extent they are protected by a privilege under either the law of the State of execution or the State of origin. 5

DISCUSSION

“ ‘A party which seeks the application of the Hague [Evidence] Convention procedures rather than the Federal Rules [of Civil Procedure] bears the burden of persuading the trial court[ ]’ of the necessity of proceeding pursuant to the Hague Evidence Convention.” 6 “That burden is not great, however, since the ‘Convention procedures are available whenever they *453 will facilitate the gathering of evidence by the means authorized in the Convention.’” 7 In this case, both parties agree that Letters of Request should be used. 8 The parties’ briefing makes clear that the inventors and declarants subject to the defendants’ motion are not parties to the lawsuit, have not voluntarily subjected themselves to discovery, are citizens of either Norway or Sweden, and are not otherwise subject to the jurisdiction of this court. Under these circumstances, it is appropriate to turn to the Hague Evidence Convention. 9

Pronova opposes only “certain details” set out in defendants’ proposed Letters of Request. 10 In its answer, Pronova provides, “Should Pronova be able to agree on the substance of the Letters of request with Defendants, Pronova would agree to join the Defendants in their motion to issue the Letters of Request.” 11 Pronova argues that the defendants’ Letters of Request are inappropriate to the extent they (1) “contain requests for clearly privileged information;” (2) “contain misleading, argumentative, and/or unfounded statements;” (3) are “unreasonably broad and include requests for information not relevant and/or not reasonably likely to be within the personal knowledge of the specified individual;” (4) “call for legal conclusions from those not qualified to make them;” (5) “request documents with no foundation of existence;” and (6) “improperly request that the deponents prepare for the deposition by going through relevant documents in advance of the deposition.” 12 The defendants characterize Pro-nova’s objections to their motion as mere attempts to inject United States procedural law where it is not required under the Hague Convention. 13

The court finds unpersuasive Pronova’s objections to the defendants’ Letters of Request based on its perception that the defendants’ requests are misleading, argumentative, overly broad, otherwise of improper form, or inappropriately call' for legal conclusions. If the defendants’ requests suffer from such maladies under the laws of Norway or Sweden, then the requests will presumably be narrowed by the appropriate judicial authorities in those countries. 14 “The court is content *454 that such officials will make the appropriate determination under their own law.” 15 Equally unpersuasive is Pronova’s objection based on what it characterizes as the defendants’ request for documents with “no foundation of existence.” As defendants argue, they cannot know exactly what specific information each witness has, and to the extent that a particular witness does not have the information requested, that witness may so state.

The court is also not convinced that the defendants must revise their Letters of Request to clarify that they will not inquire into matters which are subject to the attorney-client or any other applicable privilege, or that they will take the most restrictive view of privilege applicable, whether it be under United States, Norwegian, or Swedish law. Pronova asserts that the defendants’ Letters of Request require such revisions. As the defendants point out, however, Article 3 of the Hague Evidence Convention provides that “[a] Letter may also mention any information necessary for the application of Article 11,” 16 and Article 11 of the Hague Evidence Convention reads:

In the execution of a Letter of Request the person concerned may refuse to give evidence in so far as he has a privilege or duty to refuse to give the evidence—
a) under the law of the State of execution; or

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
708 F. Supp. 2d 450, 2010 U.S. Dist. LEXIS 41772, 2010 WL 1685998, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pronova-biopharma-norge-as-v-teva-pharmaceuticals-usa-inc-ded-2010.